Bibliometric Analysis of Trends in Stem Cell Therapy for Hip Osteoarthritis from 1990 to 2023

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Background: The rapid growth in the prevalence of hip osteoarthritis, in conjunction with the worldwide increase in the average age of the population, has attracted the interest of many researchers. Our objective was to identify research trends in stem cell therapy for hip osteoarthritis and to evaluate the most-reviewed high-quality scientific articles related to stem cells. Methods: All stem cell therapy for hip osteoarthritis publications were retrieved from the Web of Science Core Collection database. We analyzed all publications by years of publication in this field, country, institution, total citations, and journal. Publication performance was assessed by numerous bibliometric criteria, like VOSviewer, to discover topic trends in the research landscape. At the same time, the 100 stem cell articles with the most citations were extracted and analyzed. Results: A total of 1099 publications associated with stem cell therapy for hip osteoarthritis were included between 1990 and 2023. Globally, the country with the most published articles on stem cell treatment for hip osteoarthritis is the United States, with 713. Helsinki University had the most publications of any institution (n = 48). The journal " Osteoarthritis and Cartilage " has published 54 publications with a total of 3090 citations. Conclusion: This study represents the latest bibliometric analysis of stem cell therapy for hip osteoarthritis. The main objective is to highlight present and prospective research hotspots for clinicians and researchers in the field.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC-BY-4.0